Latest Articles

Publication Date
Indications and Efficacy of Progestogen-Monotherapy as Menopause Hormone Therapy: A Narrative Review.

Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen …

Published: June 25, 2026, midnight
Excess body weight raises risk for 19 cancers worldwide —Study - Tribune Online

Excess body weight raises risk for 19 cancers worldwide —Study Tribune Online

Published: June 24, 2026, 6:14 a.m.
Histone lactylation: a novel epigenetic bridge linking cellular metabolism to benign and malignant gynecological diseases.

Lactic acid modification of histones represents an emerging post-translational modification that establishes a critical link between cellular metabolic reprogramming and epigenetic regulation through the covalent binding of lactic acid to …

Published: June 23, 2026, midnight
The role of omentin-1 in female reproduction: a critical review.

White adipose tissue is now recognized as an active endocrine organ that secretes numerous bioactive molecules known as adipokines. These proteins regulate essential physiological processes, including energy metabolism, inflammation, and …

Published: June 19, 2026, midnight
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - riauone.com

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 riauone.com

Published: June 15, 2026, 12:29 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - The Manila Times

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 The Manila Times

Published: June 14, 2026, 10:21 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - NTB Kommunikasjon

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 NTB Kommunikasjon

Published: June 14, 2026, 10:05 p.m.
Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers - Medical News Bulletin

Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers Medical News Bulletin

Published: June 11, 2026, 2:44 p.m.
GLP-1 RAs Help Reduce Obesity Related Cancers - Medical News Bulletin

GLP-1 RAs Help Reduce Obesity Related Cancers Medical News Bulletin

Published: June 11, 2026, 2:37 p.m.
Raising awareness for ovarian, endometrial cancers | 11 TV Hill - WBAL-TV

Raising awareness for ovarian, endometrial cancers | 11 TV Hill WBAL-TV

Published: June 2, 2026, 1:07 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!